Service offerings include DNA/RNA extractions, cell line identification, single cell library preparation, Illumina sequencing, structural variation discovery via physical mapping with the Bionano Saphyr platform, epigenetics services, targeted gene expression panels, high density microarray services, and custom cloning services. The EIGC maintains a current Clinical Laboratory Improvement Amendments (CLIA) license to support specific genomics assays and clinical trials support.
The goal of this effort is to create a top-tier genomics resource that is widely available to the Emory research community.
Contact the Emory Integrated Genomics Core shared resource at EIGC@emory.edu.
Publication Acknowledgement Policy
The National Cancer Institute requires that publications acknowledge the Winship Cancer Institute Cancer Center Support Grant (CCSG), and it is tracking compliance. If a Winship Cancer Institute CCSG-supported Shared Resource provided data, designed the study, performed analyses, provided results used in your publication, and/or provided any systems or services that were used for the work that resulted in your publication, please include the following statement in the acknowledgment section of your publication(s):
Research reported in this publication was supported in part by the Emory Integrated Genomics Core (EIGC) shared resource of Winship Cancer Institute of Emory University and NIH/NCI under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
- Scientific Director, Emory Integrated Genomics Core
- Emory University School of Medicine
Dr. Scharer's research focuses on the transcriptional and epigenetic regulation of the immune system.